Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03060057 · ClinicalTrials.gov registry record
Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U2 Knee™ System - "U-Propel Study"
A clinical trial of Osteoarthritis, Knee, sponsored by United Orthopedic Corporation.
- Active
- Registry status
- 200
- Enrollment target
- 4
- Study locations
NCT03060057: Active study of Osteoarthritis, Knee, sponsored by United Orthopedic Corporation.
NCT03060057 is a study of Osteoarthritis, Knee that is active but no longer recruiting, run by United Orthopedic Corporation. The registered enrollment target is 200 participants, below the 496-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (60% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03060057, a study of Osteoarthritis, Knee, is active but no longer recruiting, sponsored by United Orthopedic Corporation.
- ACTIVE NOT RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to evaluate both short and long term clinical performance and safety of the commercially available U2 Knee™ System.
Conditions Studied
Interventions
- DEVICE U2 Knee™ System
Study Locations (4)
Florida
- Coastal Orthopedics - Bradenton
- Jacksonville Orthopaedic Institute - Jacksonville
- Orthopedic Center of Vero Beach - Vero Beach
Maryland
- Rubin Institute for Advanced Orthopedics - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-03-30 |
| Est. Completion | 2026-03-30 |
What the registry record for NCT03060057 still lists
NCT03060057 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 496-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which U2 Knee™ System is the first listed.
NCT03060057 reports a single indexed study location in Florida, Maryland.
Frequently Asked Questions
What is clinical trial NCT03060057 about?
NCT03060057 is a clinical study titled "Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U2 Knee™ System - "U-Propel Study"". The purpose of this study is to evaluate both short and long term clinical performance and safety of the commercially available U2 Knee™ System.
What is the current status of trial NCT03060057?
This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2017-03-30. Estimated completion is 2026-03-30.
What conditions does trial NCT03060057 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee.
What interventions are being tested in trial NCT03060057?
The interventions under investigation include: U2 Knee™ System (DEVICE).
Who is sponsoring clinical trial NCT03060057?
This trial is sponsored by United Orthopedic Corporation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03060057 being conducted?
This trial has 4 study locations across Florida, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03060057's enrollment target sits among peer trials
200 32nd of 112 higher than 78 of 112 other Osteoarthritis, Knee trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
RECRUITING · Phase 3
-
Mobilizing Hispanics With Knee Osteoarthritis
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
The Osteoarthritis Prevention Study
RECRUITING · NA
-
Preventing Injured Knees From osteoArthritis: Severity Outcomes
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI